Please see below for a list of search results.
As an establishment, you should risk assess your supply chain of reagents and consumables relating to the handling of tissues and cells.
Our shared focus should be on mitigating any potential disruption to supply including, but not limited to:
From 1 January 2021 there will be a six-month phase to allow Human Application sector establishments time to comply with any new UK import and export licensing requirements.
The UK is leaving the European Union (EU) single market and customs union when the transition period ends on the 31 December 2020.
At the end of the transition period, there will be regulatory changes within the UK.
The HTA would like to thank establishments in the HA sector for the prompt completion and return of the HA sector COVID-19 questionnaire at such a challenging time.
The HTA received a request for information on its inspections activities.
This accessibility statement applies to https://www.hta.gov.uk and all pages within it. This website is supported by Big Blue Door.How accessible the website is
We know some parts of this website are not fully accessible:
Every year, the HTA holds a public Authority meeting. This meeting is an opportunity for members of the public to attend and ask our Authority Members (the HTA Board) and the HTA’s Senior Management Team questions about our work in person.
The HTA received a request to provide records of interactions with Peter Butler and the Royal Free Hospital between 2006-2010, relating to face transplant.